RET and thyroid gland carcinoma: Another tyrosine kinase receptor that may undergo G4-dependent transcriptional regulation is the rearranged during transfection (RET) proto-oncogene, which is implicated in the initiation and progression of several human tumors [74] and represents a potential therapeutic target for the treatment of RET-associated cancers, such as thyroid cancers.